Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (97)	1/31/2001 12:26:54 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 469

I swear, I've been through the entire OGS site and have not found any report disclosing the number of shares outstanding. Not even a 99 annual report that I could use as a starting point. If I go the FT site and flip price/market cap, it looks like there are about 85 million shares out. Such 'data' has been wrong before though, and I would still dearly like to see the audited #'s, including the option info. Am I blind? More importantly, would any of you 'axes' on ogs have a rough outstanding shares number handy after the offering? I promise I will not make an investment decision based on it! At this point anything within 15% of actual would vastly improve my comfort. Also, anyone know what paraesthesiae is? Two patients dropped out of the vevesca trial because of it. --Wilder